Literature DB >> 2324299

The Brief Psychiatric Rating Scale (BPRS) and the Nurses' Observation Scale for Inpatient Evaluation (NOSIE) in the evaluation of positive and negative symptoms.

P M Dingemans1.   

Abstract

Positive and negative a priori symptom scales were operationalized with the BPRS and the NOSIE. Acutely and consecutively admitted psychiatric patients (N = 247) were rated with these scales. Research questions dealt with the psychometric properties of the scales. It was found that the positive symptom scales had sufficient internal consistency; the negative scales did not. Diagnostic groups could be distinguished better with the positive symptom (PS) than with the negative symptom (NS) scales. The outcome of this research suggests that the positive and negative symptoms distinction is less meaningful in cross-sectional research, in which acute patients are rated, than in longitudinal research.

Entities:  

Mesh:

Year:  1990        PMID: 2324299     DOI: 10.1002/1097-4679(199003)46:2<168::aid-jclp2270460207>3.0.co;2-l

Source DB:  PubMed          Journal:  J Clin Psychol        ISSN: 0021-9762


  4 in total

Review 1.  Behavioural problems associated with dementia: the role of newer antipsychotics.

Authors:  G Stoppe; C A Brandt; J H Staedt
Journal:  Drugs Aging       Date:  1999-01       Impact factor: 3.923

2.  Neuroplastic changes in patients with schizophrenia undergoing cognitive remediation: triple-blind trial.

Authors:  Ian S Ramsay; Tasha M Nienow; Matthew P Marggraf; Angus W MacDonald
Journal:  Br J Psychiatry       Date:  2017-02-02       Impact factor: 9.319

3.  Italian validation of MOAS and NOSIE: a useful package for psychiatric assessment and monitoring of aggressive behaviours.

Authors:  Francesco Margari; Rosanna Matarazzo; Massimo Casacchia; Rita Roncone; Massimiliano Dieci; Simona Safran; Giovanni Fiori; Lucia Simoni
Journal:  Int J Methods Psychiatr Res       Date:  2005       Impact factor: 4.035

4.  EPA guidance on assessment of negative symptoms in schizophrenia.

Authors:  S Galderisi; A Mucci; S Dollfus; M Nordentoft; P Falkai; S Kaiser; G M Giordano; A Vandevelde; M Ø Nielsen; L B Glenthøj; M Sabé; P Pezzella; I Bitter; W Gaebel
Journal:  Eur Psychiatry       Date:  2021-02-18       Impact factor: 5.361

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.